Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 6 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $212.75 (16.56% upside)

Current Analysts' Coverage Summary for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/6/2015ZacksUpgradeNeutral -> Outperform$214.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Citigroup Inc.Reiterated RatingHold$199.00 -> $208.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Jefferies GroupBoost Price TargetHold$161.00 -> $164.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Leerink SwannBoost Price TargetOutperform$200.00 -> $224.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Stifel NicolausBoost Price TargetBuy$230.00 -> $236.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Brean CapitalReiterated RatingBuy$215.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Piper JaffrayReiterated RatingOverweight$214.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2015BarclaysInitiated CoverageOverweight$225.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015BTIG ResearchInitiated CoverageBuy$250.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015Morgan StanleyDowngradeOverweight -> Equal Weight$202.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015NomuraDowngradeBuy -> Neutral$224.00 -> $223.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$220.00 -> $225.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageBuy$197.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014SunTrustInitiated CoverageBuy$229.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Goldman SachsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/25/2013OppenheimerBoost Price Target$115.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Wells Fargo & Co.Reiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
4/19/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/4/2013 forward)